BioSpace News Archive

Albany NY, United States: The global skin boosters market is anticipated to expand at a favorable rate from 2021 to 2031.

ANGLE plc, a world-leading liquid biopsy company, is pleased to announce that Prostate Cancer UK has approved funding for a significant clinical study at Barts Cancer Institute, Queen Mary University of London.

Smart Immune announced it has delivered an oral presentation on its preclinical research at the 25th American Society of Gene and Cell Therapy Annual Meeting, which took place from May 16-19 in Washington DC, USA.

ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced the presentation of a poster highlighting new data and insights related to neuronal itch mechanisms through eblasakimab’s targeting of IL-13Rα1 at the Society for Investigative Dermatology (SID) Annual Meeting.

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices, will provide an update on its business and address its 2023-2025 business growth strategy and financial goals during its 2022 Analyst & Investor Day today in New York City.

Apiary Medical, Inc. today announced the strategic acquisition of Manus Medical LLC, one of the leading SDVOSB providers of procedural packs for the federal government.

Collaboration combines Clario’s eCOA innovations with Cogstate’s expertise in neuroscience research to yield highest quality endpoints.